1752-8054

Clinical and Translational Science

Wiley (Blackwell Publishing)

View prefix report (10.1111)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1852 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1852 DOIs
2

Add abstracts to 741 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact741 DOIs
3

Deposit reference lists for 463 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact463 DOIs

DOIs for this ISSN

Showing the top 5 of 2951 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Lessons Learned from Alzheimer Disease: Clinical Trials with… (10.1111/cts.12491)
Abstract ORCID
121.57 269
2 Future of Rare Diseases Research 2017–2027: An IRDiRC Perspe… (10.1111/cts.12500)
Abstract ORCID
116.72 215
3 Immunotherapy and Novel Combinations in Oncology: Current La… (10.1111/cts.12391)
Abstract ORCID
109.38 153
4 Progress in Rare Diseases Research 2010–2016: An IRDiRC Pers… (10.1111/cts.12501)
Abstract ORCID
106.84 136
5 Chronic Diseases: The Emerging Pandemic (10.1111/j.1752-8062.2011.00295.x)
Abstract ORCID
104.32 121
6 Gene Therapy 2017: Progress and Future Directions (10.1111/cts.12466)
Abstract ORCID
103.78 118
7 Importance of Drug Pharmacokinetics at the Site of Action (10.1111/cts.12448)
Abstract ORCID
103.22 115
8 Microdosing and Other Phase 0 Clinical Trials: Facilitating… (10.1111/cts.12390)
Abstract ORCID
97.22 87
9 The IGNITE Pharmacogenetics Working Group: An Opportunity fo… (10.1111/cts.12456)
Abstract ORCID
95.15 79
10 Enabling a Learning Health System through a Unified Enterpri… (10.1111/cts.12294)
Abstract ORCID
94.88 78
11 Implementing Pharmacogenomics at Your Institution: Establish… (10.1111/cts.12404)
Abstract ORCID
94.60 77
12 What Do We Know About Remdesivir Drug Interactions? (10.1111/cts.12815)
Abstract ORCID
94.32 76
13 Precision Dosing: Public Health Need, Proposed Framework, an… (10.1111/cts.12490)
Abstract ORCID
93.75 74
14 Corneal Regeneration Following Implantation of a Biomimetic… (10.1111/j.1752-8062.2008.00083.x)
Abstract ORCID
93.75 74
15 Clinical Pharmacology and Translational Aspects of Bispecifi… (10.1111/cts.12459)
Abstract ORCID
92.87 71
16 It's Time to Reverse our Thinking: The Reverse Translation R… (10.1111/cts.12538)
Abstract ORCID
92.56 70
17 Clinical and Translational Science: From Bench‐Bedside to Gl… (10.1111/j.1752-8062.2010.00227.x)
Abstract ORCID
91.63 67
18 Role of CYP3A in Oral Contraceptives Clearance (10.1111/cts.12499)
Abstract ORCID
90.31 63
19 Toward A Universal Biomedical Data Translator (10.1111/cts.12591)
Abstract ORCID
90.31 63
20 Challenges and Opportunities in Dose Finding in Oncology and… (10.1111/cts.12540)
Abstract ORCID
88.54 58
21 Systematic Review of Quantitative Measures of Stakeholder En… (10.1111/cts.12474)
Abstract ORCID
88.17 57
22 Right Drug—Right Patient—Right Time: Personalized Medicine C… (10.1111/j.1752-8062.2008.00003.x)
Abstract ORCID
87.41 55
23 Personalized Medicine in Europe (10.1111/cts.12446)
Abstract ORCID
86.21 52
24 The National Institutes of Health Physician‐Scientist Workfo… (10.1111/cts.12209)
Abstract ORCID
84.06 47
25 Genome‐wide and Phenome‐wide Approaches to Understand Variab… (10.1111/cts.12522)
Abstract ORCID
83.60 46
26 Microphysiological Systems (“Organs‐on‐Chips”) for Drug Effi… (10.1111/cts.12444)
Abstract ORCID
83.14 45
27 Reverse Translation of US Food and Drug Administration Revie… (10.1111/cts.12527)
Abstract ORCID
82.17 43
28 Leukocyte Cell‐Derived Chemotaxin‐2: It's Role in Pathophysi… (10.1111/cts.12469)
Abstract ORCID
81.16 41
29 Relationships Hold the Key to Trustworthy and Productive Tra… (10.1111/cts.12022)
Abstract ORCID
80.64 40
30 Precision Medicine, AI, and the Future of Personalized Healt… (10.1111/cts.12884)
ORCID
80.28 1626
31 Pharmacometabolomics in Early‐Phase Clinical Development (10.1111/cts.12396)
Abstract ORCID
79.55 38
32 The Role of Next‐Generation Sequencing in Enabling Personali… (10.1111/cts.12429)
Abstract ORCID
79.55 38
33 High‐Throughput Assays to Assess the Functional Impact of Ge… (10.1111/cts.12440)
Abstract ORCID
78.99 37
34 White Paper on CTSA Consortium Role in Facilitating Comparat… (10.1111/j.1752-8062.2010.00177.x)
Abstract ORCID
77.82 35
35 The Biomedical Data Translator Program: Conception, Culture,… (10.1111/cts.12592)
Abstract ORCID
77.20 34
36 The Advantages and Challenges of Using Real‐World Data for P… (10.1111/cts.12683)
Abstract ORCID
77.20 34
37 Translational Medicine Lessons from Flurizan's Failure in Al… (10.1111/j.1752-8062.2009.00121.x)
Abstract ORCID
75.93 32
38 Artificial Intelligence in Radiology: A Call for Thoughtful… (10.1111/cts.12704)
Abstract ORCID
74.57 30
39 Antinuclear antibodies in COVID 19 (10.1111/cts.13026)
Abstract ORCID
73.86 29
40 Bench‐to‐Bedside; Clinical and Translational Research; Perso… (10.1111/cts.12302)
Abstract ORCID
73.12 28
41 Mechanisms of Action and Clinical Development of Elotuzumab (10.1111/cts.12532)
Abstract ORCID
73.12 28
42 Early Vision for the CTSA Program Trial Innovation Network:… (10.1111/cts.12463)
Abstract ORCID
70.75 25
43 Clinical Data: Sources and Types, Regulatory Constraints, Ap… (10.1111/cts.12638)
Abstract ORCID
70.75 25
44 Immunogenicity in Clinical Practice and Drug Development: Wh… (10.1111/cts.12717)
Abstract ORCID
70.75 25
45 Toward Optimum Benefit‐Risk and Reduced Access Lag For Cance… (10.1111/cts.12386)
Abstract ORCID
69.90 24
46 Treatments and Preventative Measures for Trauma‐Induced Hete… (10.1111/cts.12552)
Abstract ORCID
69.90 24
47 The economics of moonshots: Value in rare disease drug devel… (10.1111/cts.13270)
Abstract ORCID
69.90 24
48 Recommendations for Planning Pilot Studies in Clinical and T… (10.1111/j.1752-8062.2011.00347.x)
ORCID
68.72 560
49 The Role of Public–Private Partnerships in Catalyzing the Cr… (10.1111/cts.12488)
Abstract ORCID
68.09 22
50 In Pursuit of Greater Reproducibility and Credibility of Ear… (10.1111/cts.12449)
Abstract ORCID
67.12 21